Lung transplant (LuTx) recipients are at a higher risk of developing serious illnesses from COVID-19, and thus, we have closely reviewed the consequences of the COVID-19 pandemic on lung transplantation. In most transplant centers, the overall LuTx activity significantly declined and led to a specific period of restricting lung transplantation to urgent cases. Moreover, several transplant centers reported difficulties due to the shortage of ICU capacities. The fear of donor-derived transmission generated extensive screening programs. Nevertheless, reasonable concerns about the unnecessary losses of viable organs were also raised. The overall donor shortage resulted in increased waiting-list mortality, and COVID-19-associated ARDS became an indication of lung transplantation. The impact of specific immunosuppressive agents on the severity of COVID-19 varied. Corticosteroid discontinuation was not found to be beneficial for LuTx patients. Tacrolimus concentrations were reported to increase during the SARS-CoV-2 infection, and in combination with remdesivir, tacrolimus may clinically impact renal functions. Monoclonal antibodies were shown to reduce the risk of hospitalization in SOT recipients. However, understanding the pharmacological interactions between the anti-COVID-19 drugs and the immunosuppressive drugs requires further research.

Department of Immunology 2nd Faculty of Medicine Charles University University Hospital Motol 150 06 Prague Czech Republic

Prague Lung Transplant Program 3rd Department of Surgery 1st Faculty of Medicine Charles University University Hospital Motol 150 06 Prague Czech Republic

Zobrazit více v PubMed

Tassone D., Thompson A., Connell W., Lee T., Ungaro R., An P., Ding Y., Ding N.S. Immunosuppression as a risk factor for COVID-19: A meta-analysis. Intern. Med. J. 2021;51:199–205. doi: 10.1111/imj.15142. PubMed DOI PMC

Mohammed A.H., Blebil A., Dujaili J., Rasool-Hassan B.A. The Risk and Impact of COVID-19 Pandemic on Immunosuppressed Patients: Cancer, HIV, and Solid Organ Transplant Recipients. AIDS Rev. 2020;22:151–157. doi: 10.24875/AIDSRev.20000052. PubMed DOI

Kamp J.C., Hinrichs J.B., Fuge J., Ewen R., Gottlieb J. COVID-19 in lung transplant recipients—Risk prediction and outcomes. PLoS ONE. 2021;16:e0257807. doi: 10.1371/journal.pone.0257807. PubMed DOI PMC

Rodrigues B., Daoud D., Li G., Segraves J., Hemmersbach-Miller M., Loor G., Garcha P. COVID-19 in Lung-Transplant Recipients: A Descriptive Study. J. Heart Lung Transplant. 2021;40:S315. doi: 10.1016/j.healun.2021.01.893. DOI

Novysedlak R., Vachtenheim J., Jr., Striz I., Viklicky O., Lischke R., Strizova Z. SARS-CoV-2 viral load assessment in lung transplantation. Physiol. Res. 2021;70:S253–S258. doi: 10.33549/physiolres.934760. PubMed DOI PMC

DeFilippis E.M., Sinnenberg L., Reza N., Givertz M.M., Kittleson M.M., Topkara V.K., Farr M.A. Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) Pandemic. JAMA Cardiol. 2020;5:1048–1052. doi: 10.1001/jamacardio.2020.2696. PubMed DOI PMC

Manara A.R., Mumford L., Callaghan C.J., Ravanan R., Gardiner D. Donation and transplantation activity in the UK during the COVID-19 lockdown. Lancet. 2020;396:465–466. doi: 10.1016/S0140-6736(20)31692-5. PubMed DOI PMC

Lieberman J.A., Mays J.A., Wells C., Cent A., Bell D., Bankson D.D., Greninger A.L., Jerome K.R., Limaye A.P. Expedited SARS-CoV-2 screening of donors and recipients supports continued solid organ transplantation. Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg. 2020;20:3106–3112. doi: 10.1111/ajt.16081. PubMed DOI PMC

Coiffard B., Lepper P.M., Prud’Homme E., Daviet F., Cassir N., Wilkens H., Hraiech S., Langer F., Thomas P.A., Reynaud-Gaubert M., et al. Management of lung transplantation in the COVID-19 era—An international survey. Am. J. Transplant. 2021;21:1586–1596. doi: 10.1111/ajt.16368. PubMed DOI PMC

Ashfaq A., Gray G.M., Carapellucci J., Amankwah E.K., Ahumada L.M., Rehman M., Puchalski M., Smith A., Quintessenza J.A., Asante-Korang A. Impact of Coronavirus-2019 On Pediatric and Adult Heart Transplantation Waitlist Activity and Mortality in The United States: A Descriptive Approach. Lancet Reg. Health—Am. 2021;3:100060. doi: 10.1016/j.lana.2021.100060. PubMed DOI PMC

Anderson M.S., Valbuena V.S.M., Brown C.S., Waits S.A., Sonnenday C.J., Englesbe M., Mellinger J.L. Association of COVID-19 With New Waiting List Registrations and Liver Transplantation for Alcoholic Hepatitis in the United States. JAMA Netw. Open. 2021;4:e2131132. doi: 10.1001/jamanetworkopen.2021.31132. PubMed DOI PMC

Craig-Schapiro R., Salinas T., Lubetzky M., Abel B.T., Sultan S., Lee J.R., Kapur S., Aull M.J., Dadhania D.M. COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients. Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg. 2021;21:1576–1585. doi: 10.1111/ajt.16351. PubMed DOI PMC

Brosnahan S.B., Jonkman A.H., Kugler M.C., Munger J.S., Kaufman D.A. COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical and Translational Research Questions. Arterioscler. Thromb. Vasc. Biol. 2020;40:2586–2597. doi: 10.1161/ATVBAHA.120.314515. PubMed DOI PMC

Walter K. Lung Transplants for COVID-19—The Option of Last Resort. JAMA. 2021;326:14–16. doi: 10.1001/jama.2021.9363. PubMed DOI

Kumar D., Humar A., Keshavjee S., Cypel M. A call to routinely test lower respiratory tract samples for SARS-CoV-2 in lung donors. Am. J. Transpl. 2021;21:2623–2624. doi: 10.1111/ajt.16576. PubMed DOI PMC

Gok E., Patel M., Stojkovic B.P., Patel J., Dinh K., Hussein R., Akkanti B., Gregoric I., Jyothula S.S. Lung Transplantation in COVID 19 ARDS—Short Term Outcomes. J. Heart Lung Transplant. 2021;40:S500–S501. doi: 10.1016/j.healun.2021.01.2035. DOI

Sharma P., Chen V., Fung C.M., Troost J.P., Patel V.N., Combs M., Norman S., Garg P., Colvin M., Aaronson K., et al. COVID-19 Outcomes Among Solid Organ Transplant Recipients: A Case-control Study. Transplantation. 2021;105:128–137. doi: 10.1097/TP.0000000000003447. PubMed DOI PMC

Ahn C., Amer H., Anglicheau D., Ascher N.L., Baan C.C., Battsetset G., Bat-Ireedui B., Berney T., Betjes M.G.H., Bichu S., et al. Global Transplantation COVID Report March 2020. Transplantation. 2020;104:1974–1983. doi: 10.1097/TP.0000000000003258. PubMed DOI PMC

Aubert O., Yoo D., Zielinski D., Cozzi E., Cardillo M., Dürr M., Domínguez-Gil B., Coll E., Da Silva M.I., Sallinen V., et al. COVID-19 pandemic and worldwide organ transplantation: A population-based study. Lancet. Public Health. 2021;6:e709–e719. doi: 10.1016/S2468-2667(21)00200-0. PubMed DOI PMC

Benvenuto L., Snyder M.E., Aversa M., Patel S., Costa J., Shah L., Robbins H., D'Ovidio F., Sonett J., Stanifer B.P., et al. Geographic Differences in Lung Transplant Volume and Donor Availability During the COVID-19 Pandemic. Transplantation. 2021;105:861–866. doi: 10.1097/TP.0000000000003600. PubMed DOI PMC

Johal M.S., Granger E.K., Jansz P., Connellan M., Watson A., Iyer A., Malouf M.A., Havryk A.P., Plit M. Impact of COVID-19 on Lung Transplantation in Australia. J. Heart Lung Transplant. 2021;40:S142. doi: 10.1016/j.healun.2021.01.438. DOI

Hardman G., Sutcliffe R., Hogg R., Mumford L., Grocott L., Mead-Regan S.J., Nuttall J., Dunn S., Seeley P., Clark S., et al. The impact of the SARS-CoV-2 pandemic and COVID-19 on lung transplantation in the UK: Lessons learned from the first wave. Clin. Transplant. 2021;35:e14210. doi: 10.1111/ctr.14210. PubMed DOI PMC

Michel S., Witt C., Gottlieb J., Aigner C. Impact of COVID-19 on Lung Transplant Activity in Germany-A Cross-Sectional Survey. Thorac. Cardiovasc. Surg. 2021;69:92–94. doi: 10.1055/s-0040-1715436. PubMed DOI

Ribeiro Junior M.A.F., Costa C.T.K., Néder P.R., Aveiro I.A., Elias Y.G.B., Augusto S.S. Impact of COVID-19 on the number of transplants performed in Brazil during the pandemic. Current situation. Rev. Do Col. Bras. De Cir. 2021;48:e20213042. doi: 10.1590/0100-6991e-20213042. PubMed DOI PMC

Kwapisz M., Małkowski P., Tronina O., Wasiak D., Czerwiński J., Polak W.G., Kosieradzki M. Effects of the COVID-19 Pandemic on Solid Organ Transplantation During 2020 in Poland Compared with Countries in Western Europe, Asia, and North America: A Review. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2021;27:e932025. doi: 10.12659/MSM.932025. PubMed DOI PMC

Ceulemans L.J., Van Slambrouck J., De Leyn P., Decaluwe H., Van Veer H., Depypere L., Ceuterick V., Verleden S.E., Vanstapel A., Desmet S., et al. Successful double-lung transplantation from a donor previously infected with SARS-CoV-2. Lancet Respir. Med. 2021;9:315–318. doi: 10.1016/S2213-2600(20)30524-5. PubMed DOI PMC

Querrey M., Kurihara C., Manerikar A., Garza-Castillon R., Lysne J., Tomic R., Budinger G.S., Kim S., Lung K., Yeldandi A., et al. Lung donation following SARS-CoV-2 infection. Am. J. Transpl. 2021;21:4073–4078. doi: 10.1111/ajt.16777. PubMed DOI PMC

Kaul D.R., Valesano A.L., Petrie J.G., Sagana R., Lyu D., Lin J., Stoneman E., Smith L.M., Lephart P., Lauring A.S. Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing. Am. J. Transpl. 2021;21:2885–2889. doi: 10.1111/ajt.16532. PubMed DOI PMC

Greenwald M.A., Kuehnert M.J., Fishman J.A. Infectious disease transmission during organ and tissue transplantation. Emerg. Infect. Dis. 2012;18:e1. doi: 10.3201/eid1808.120277. PubMed DOI PMC

Halpern S.E., Olaso D.G., Krischak M.K., Reynolds J.M., Haney J.C., Klapper J.A., Hartwig M.G. Lung transplantation during the COVID-19 pandemic: Safely navigating the new “normal”. Am. J. Transplant. 2020;20:3094–3105. doi: 10.1111/ajt.16304. PubMed DOI PMC

Wang W., Xu Y., Gao R., Lu R., Han K., Wu G., Tan W. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020;323:1843–1844. doi: 10.1001/jama.2020.3786. PubMed DOI PMC

Murphy K. SARS CoV-2 Detection From Upper and Lower Respiratory Tract Specimens: Diagnostic and Infection Control Implications. Chest. 2020;158:1804–1805. doi: 10.1016/j.chest.2020.07.061. PubMed DOI PMC

Strizova Z., Smetanova J., Bartunkova J., Milota T. Principles and Challenges in anti-COVID-19 Vaccine Development. Int Arch. Allergy Immunol. 2021;182:339–349. doi: 10.1159/000514225. PubMed DOI PMC

Amadi C.C., Galizia M.S., Mortani Barbosa E.J., Jr. Imaging Evaluation of Lung Transplantation Patients: A Time and Etiology-based Approach to High-resolution Computed Tomography Interpretation. J. Thorac. Imaging. 2019;34:299–312. doi: 10.1097/RTI.0000000000000419. PubMed DOI

Zimmermann J., Glueck O.M., Fertmann J.M., Sienel W.G., Yavuz G., Damirov F., Kovacs J.R., Tufman A., Irlbeck M., Kneidinger N., et al. COVID-19 in Recent Lung Transplant Recipients: Clinical Outcomes and Management Strategies. Transpl. Proc. 2022;54:1–13. doi: 10.1016/j.transproceed.2021.12.014. PubMed DOI PMC

Olalla J. Remdesivir for the Treatment of COVID-19—Preliminary Report. N. Engl. J. Med. 2020;383:993–994. doi: 10.1056/NEJMc2022236. PubMed DOI

Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S., Huang H., Zhang L., Zhou X., Du C., et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern. Med. 2020;180:934–943. doi: 10.1001/jamainternmed.2020.0994. PubMed DOI PMC

Schaheen L., Bremner R.M., Walia R., Smith M.A. Lung transplantation for coronavirus disease 2019 (COVID-19): The who, what, where, when, and why. J. Thorac. Cardiovasc. Surg. 2021;163:865. doi: 10.1016/j.jtcvs.2021.06.061. PubMed DOI PMC

Bharat A., Machuca T.N., Querrey M., Kurihara C., Garza-Castillon R., Jr., Kim S., Manerikar A., Pelaez A., Pipkin M., Shahmohammadi A., et al. Early outcomes after lung transplantation for severe COVID-19: A series of the first consecutive cases from four countries. Lancet Respir. Med. 2021;9:487–497. doi: 10.1016/S2213-2600(21)00077-1. PubMed DOI PMC

Glorion M., De Wolf J., Zuber B., Cassiano F., Preau S., Brun A.L., Cohen J., Tachon G., Neuville M., Brugiere O., et al. Lung transplantation for COVID-19-associated acute respiratory distress syndrome: The first French patient. Respir. Med. Res. 2021;80:100851. doi: 10.1016/j.resmer.2021.100851. PubMed DOI PMC

Yusen R.D., Edwards L.B., Dipchand A.I., Goldfarb S.B., Kucheryavaya A.Y., Levvey B.J., Lund L.H., Meiser B., Rossano J.W., Stehlik J., et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant. J. Heart Lung Transpl. 2016;35:1170–1184. doi: 10.1016/j.healun.2016.09.001. PubMed DOI

Frick A.E., Gan C.T., Vos R., Schwarz S., Kraft F., Kifjak D., Neyrinck A.P., Van Raemdonck D.E., Klepetko W., Jaksch P., et al. Lung transplantation for acute respiratory distress syndrome: A multicenter experience. Am. J. Transpl. 2022;22:144–153. doi: 10.1111/ajt.16759. PubMed DOI PMC

Chang Y., Lee S.O., Shim T.S., Choi S.H., Kim H.R., Kim Y.H., Kim D.K., Do K.H., Choi I.C., Hong S.B., et al. Lung Transplantation as a Therapeutic Option in Acute Respiratory Distress Syndrome. Transplantation. 2018;102:829–837. doi: 10.1097/TP.0000000000002004. PubMed DOI

Gottlieb J., Lepper P.M., Berastegui C., Montull B., Wald A., Parmar J., Magnusson J.M., Schönrath F., Laisaar T., Michel S., et al. Lung transplantation for acute respiratory distress syndrome—A retrospective European Cohort Study. Eur. Respir. J. 2021;9 doi: 10.1183/13993003.02078-2021. PubMed DOI

Tran D.H., Peng C.C., Wolde-Rufael D.A., Devkota H., Diaz-Abad M., Baghdadi J., Chow R.D., Verceles A.C. A successful case of extracorporeal membrane oxygenation for COVID-19: Walking home without oxygen supplementation. J. Community Hosp. Intern. Med. Perspect. 2021;11:480–484. doi: 10.1080/20009666.2021.1918442. PubMed DOI PMC

Luyt C.E., Combes A., Becquemin M.H., Beigelman-Aubry C., Hatem S., Brun A.L., Zraik N., Carrat F., Grenier P.A., Richard J.M., et al. Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Chest. 2012;142:583–592. doi: 10.1378/chest.11-2196. PubMed DOI

Lepper P.M., Langer F., Wilkens H., Schafers H.J., Bals R. Lung transplantation for COVID-19-associated ARDS. Lancet Respir. Med. 2021;9:e88. doi: 10.1016/S2213-2600(21)00278-2. PubMed DOI PMC

Lang C., Ritschl V., Augustin F., Lang G., Moser B., Taghavi S., Murakoezy G., Lambers C., Flick H., Koestenberger M., et al. Clinical relevance of lung transplantation for COVID-19 ARDS: A nationwide study. Eur. Respir. J. 2022 doi: 10.1183/13993003.02404-2021. PubMed DOI PMC

Cypel M., Keshavjee S. When to consider lung transplantation for COVID-19. Lancet Respir. Med. 2020;8:944–946. doi: 10.1016/S2213-2600(20)30393-3. PubMed DOI PMC

Weill D., Benden C., Corris P.A., Dark J.H., Davis R.D., Keshavjee S., Lederer D.J., Mulligan M.J., Patterson G.A., Singer L.G., et al. A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J. Heart Lung Transpl. 2015;34:1–15. doi: 10.1016/j.healun.2014.06.014. PubMed DOI

Schechter M.A., Ganapathi A.M., Englum B.R., Speicher P.J., Daneshmand M.A., Davis R.D., Hartwig M.G. Spontaneously Breathing Extracorporeal Membrane Oxygenation Support Provides the Optimal Bridge to Lung Transplantation. Transplantation. 2016;100:2699–2704. doi: 10.1097/TP.0000000000001047. PubMed DOI PMC

Hama Amin B.J., Kakamad F.H., Ahmed G.S., Ahmed S.F., Abdulla B.A., Mohammed S.H., Mikael T.M., Salih R.Q., Ali R.K., Salh A.M., et al. Post COVID-19 pulmonary fibrosis; a meta-analysis study. Ann. Med. Surg. 2022;77:103590. doi: 10.1016/j.amsu.2022.103590. PubMed DOI PMC

Gogia P., Attawar S., Singh V., Bhatnagar T., Sharma S., Batra K., Khare S. Lung transplantation for post-COVID-19 pulmonary fibrosis. Respirol. Case Rep. 2021;9:e0862. doi: 10.1002/rcr2.862. PubMed DOI PMC

Hall D.J., Schulte J.J., Lewis E.E., Bommareddi S.R., Rohrer C.T., Sultan S., Maloney J.D., DeCamp M.M., McCarthy D.P. Successful Lung Transplantation for Severe Post COVID-19 Pulmonary Fibrosis. Ann. Thorac. Surg. 2021 doi: 10.1016/j.athoracsur.2021.10.004. PubMed DOI PMC

Mohammadi A., Balan I., Yadav S., Matos W.F., Kharawala A., Gaddam M., Sarabia N., Koneru S.C., Suddapalli S.K., Marzban S. Post-COVID-19 Pulmonary Fibrosis. Cureus. 2022;14:e22770. doi: 10.7759/cureus.22770. PubMed DOI PMC

Russell B., Moss C., George G., Santaolalla A., Cope A., Papa S., Van Hemelrijck M. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience. 2020;14:1022. doi: 10.3332/ecancer.2020.1022. PubMed DOI PMC

Schoot T.S., Kerckhoffs A.P.M., Hilbrands L.B., van Marum R.J. Immunosuppressive Drugs and COVID-19: A Review. Front. Pharmacol. 2020;11:1333. doi: 10.3389/fphar.2020.01333. PubMed DOI PMC

Castelnovo L., Tamburello A., Lurati A., Zaccara E., Marrazza M.G., Olivetti M., Mumoli N., Mastroiacovo D., Colombo D., Ricchiuti E., et al. Anti-IL6 treatment of serious COVID-19 disease: A monocentric retrospective experience. Medicine. 2021;100:e23582. doi: 10.1097/MD.0000000000023582. PubMed DOI PMC

Franzetti M., Forastieri A., Borsa N., Pandolfo A., Molteni C., Borghesi L., Pontiggia S., Evasi G., Guiotto L., Erba M., et al. IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study. J. Immunol. (Baltim. Md. 1950) 2021;206:1569–1575. doi: 10.4049/jimmunol.2001126. PubMed DOI PMC

Kronbichler A., Gauckler P., Windpessl M., Il Shin J., Jha V., Rovin B.H., Oberbauer R. COVID-19: Implications for immunosuppression in kidney disease and transplantation. Nat. Rev. Nephrol. 2020;16:365–367. doi: 10.1038/s41581-020-0305-6. PubMed DOI PMC

Villarroel M.C., Hidalgo M., Jimeno A. Mycophenolate mofetil: An update. Drugs Today. 2009;45:521–532. doi: 10.1358/dot.2009.45.7.1384878. PubMed DOI

Kato F., Matsuyama S., Kawase M., Hishiki T., Katoh H., Takeda M. Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2. Microbiol. Immunol. 2020;64:635–639. doi: 10.1111/1348-0421.12828. PubMed DOI PMC

Lai Q., Spoletini G., Bianco G., Graceffa D., Agnes S., Rossi M., Lerut J. SARS-CoV2 and immunosuppression: A double-edged sword. Transpl. Infect. Dis. 2020;22:e13404. doi: 10.1111/tid.13404. PubMed DOI PMC

Zhong Z., Zhang Q., Xia H., Wang A., Liang W., Zhou W., Zhou L., Liu X., Rao L., Li Z., et al. Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients. Am. J. Transplant. 2020;20:1916–1921. doi: 10.1111/ajt.15928. PubMed DOI PMC

Zaidan M., Legendre C. Solid Organ Transplantation in the Era of COVID-19: Lessons from France. Transplantation. 2021;105:61–66. doi: 10.1097/TP.0000000000003536. PubMed DOI

Treede H., Klepetko W., Reichenspurner H., Zuckermann A., Meiser B., Birsan T., Wisser W., Reichert B. Tacrolimus versus cyclosporine after lung transplantation: A prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant. 2001;20:511–517. doi: 10.1016/S1053-2498(01)00244-3. PubMed DOI

Devaux C.A., Melenotte C., Piercecchi-Marti M.-D., Delteil C., Raoult D. Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19? Front. Med. 2021;8:663708. doi: 10.3389/fmed.2021.663708. PubMed DOI PMC

Willicombe M., Thomas D., McAdoo S. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm? J. Am. Soc. Nephrol. 2020;31:1145–1146. doi: 10.1681/ASN.2020030348. PubMed DOI PMC

Sessa A., Mazzola A., Lim C., Atif M., Pappatella J., Pourcher V., Scatton O., Conti F. COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case report. World J. Gastroenterol. 2020;26:7076–7084. doi: 10.3748/wjg.v26.i44.7076. PubMed DOI PMC

Salerno D.M., Kovac D., Corbo H., Jennings D.L., Lee J., Choe J., Scheffert J., Hedvat J., Chen J., Tsapepas D., et al. SARS-CoV-2 infection increases tacrolimus concentrations in solid-organ transplant recipients. Clin. Transplant. 2021;35:e14193. doi: 10.1111/ctr.14193. PubMed DOI PMC

Chung P.A., Dilling D.F. Immunosuppressive strategies in lung transplantation. Ann. Transl. Med. 2020;8:409. doi: 10.21037/atm.2019.12.117. PubMed DOI PMC

Rabaan A.A., Al-Ahmed S.H., Muhammad J., Khan A., Sule A.A., Tirupathi R., Mutair A.A., Alhumaid S., Al-Omari A., Dhawan M., et al. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines. 2021;9:436. doi: 10.3390/vaccines9050436. PubMed DOI PMC

Brugiere O., Neuville M., Le Balch P., Le Tulzo Y., Brun A.L., Hamid A., Beaumont L., Roux A., Jouneau S., Parquin F. COVID-19 in Lung Transplant Recipients: 2 Cases With Acute Respiratory Distress Syndrome Successfully Treated With High-Dose Corticosteroids. Exp. Clin. Transplant. Off. J. Middle East Soc. Organ Transplant. 2021;19:744–748. doi: 10.6002/ect.2021.0007. PubMed DOI

Ruttens D., Verleden S.E., Vandermeulen E., Bellon H., Vanaudenaerde B.M., Somers J., Schoonis A., Schaevers V., Van Raemdonck D.E., Neyrinck A., et al. Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial. Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg. 2016;16:254–261. doi: 10.1111/ajt.13417. PubMed DOI

Li D., Duan Q., Weinkauf J., Kapasi A., Varughese R., Hirji A., Lien D., Meyer S., Laing B., Nagendran J., et al. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival. J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant. 2020;39:1426–1434. doi: 10.1016/j.healun.2020.09.006. PubMed DOI

Verleden G.M., Godinas L., Lorent N., Van Bleyenbergh P., Dupont L., Delcroix M., Yserbyt J., Dooms C., Vos R. COVID-19 in lung transplant patients: A case series. Am. J. Transplant. 2020;20:3234–3238. doi: 10.1111/ajt.16212. PubMed DOI PMC

Pereira M.R., Arcasoy S., Farr M.A., Mohan S., Emond J.C., Tsapepas D.S., Shi Q., Purpura L., Uhlemann A.-C., Zucker J., et al. Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study. Transpl. Infect. Dis. 2021;23:e13637. doi: 10.1111/tid.13637. PubMed DOI PMC

Bos S., De Sadeleer L.J., Yserbyt J., Dupont L.J., Godinas L., Verleden G.M., Ceulemans L.J., Vanaudenaerde B.M., Vos R. Real life experience with mTOR-inhibitors after lung transplantation. Int. Immunopharmacol. 2021;94:107501. doi: 10.1016/j.intimp.2021.107501. PubMed DOI

Messika J., Eloy P., Roux A., Hirschi S., Nieves A., Le Pavec J., Sénéchal A., Saint Raymond C., Carlier N., Demant X., et al. COVID-19 in Lung Transplant Recipients. Transplantation. 2021;105:177–186. doi: 10.1097/TP.0000000000003508. PubMed DOI

Group R.C., Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L., Staplin N., Brightling C., Ustianowski A., et al. Dexamethasone in Hospitalized Patients with COVID-19. N. Engl. J. Med. 2021;384:693–704. doi: 10.1056/NEJMoa2021436. PubMed DOI PMC

Aversa M., Benvenuto L., Anderson M., Shah L., Robbins H., Pereira M., Scheffert J., Carroll M., Hum J., Nolan M., et al. COVID-19 in lung transplant recipients: A single center case series from New York City. Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg. 2020;20:3072–3080. doi: 10.1111/ajt.16241. PubMed DOI PMC

Lam S., Partovi N., Ting L.S., Ensom M.H. Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: Fact or fiction? Ann. Pharmacother. 2008;42:1037–1047. doi: 10.1345/aph.1K628. PubMed DOI

Buxeda A., Arias-Cabrales C., Pérez-Sáez M.J., Cacho J., Cabello Pelegrin S., Melilli E., Aladrén M.J., Galeano C., Lorenzo I., Mazuecos A., et al. Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19. Kidney Int. Rep. 2021;6:2305–2315. doi: 10.1016/j.ekir.2021.06.023. PubMed DOI PMC

Buehrle D.J., Sutton R.R., McCann E.L., Lucas A.E. A Review of Treatment and Prevention of Coronavirus Disease 2019 among Solid Organ Transplant Recipients. Viruses. 2021;13:1706. doi: 10.3390/v13091706. PubMed DOI PMC

Beigel J.H., Tomashek K.M., Dodd L.E., Mehta A.K., Zingman B.S., Kalil A.C., Hohmann E., Chu H.Y., Luetkemeyer A., Kline S., et al. Remdesivir for the Treatment of COVID-19—Final Report. N. Engl. J. Med. 2020;383:1813–1826. doi: 10.1056/NEJMoa2007764. PubMed DOI PMC

Goldman J.D., Lye D.C.B., Hui D.S., Marks K.M., Bruno R., Montejano R., Spinner C.D., Galli M., Ahn M.-Y., Nahass R.G., et al. Remdesivir for 5 or 10 Days in Patients with Severe COVID-19. N. Engl. J. Med. 2020;383:1827–1837. doi: 10.1056/NEJMoa2015301. PubMed DOI PMC

Consortium W.H.O.S.T., Pan H., Peto R., Henao-Restrepo A.M., Preziosi M.P., Sathiyamoorthy V., Abdool Karim Q., Alejandria M.M., Hernandez Garcia C., Kieny M.P., et al. Repurposed Antiviral Drugs for COVID-19—Interim WHO Solidarity Trial Results. N. Engl. J. Med. 2021;384:497–511. doi: 10.1056/NEJMoa2023184. PubMed DOI PMC

Manabe T., Kambayashi D., Akatsu H., Kudo K. Favipiravir for the treatment of patients with COVID-19: A systematic review and meta-analysis. BMC Infect. Dis. 2021;21:489. doi: 10.1186/s12879-021-06164-x. PubMed DOI PMC

Rojas M., Rodríguez Y., Monsalve D.M., Acosta-Ampudia Y., Camacho B., Gallo J.E., Rojas-Villarraga A., Ramírez-Santana C., Díaz-Coronado J.C., Manrique R., et al. Convalescent plasma in COVID-19: Possible mechanisms of action. Autoimmun. Rev. 2020;19:102554. doi: 10.1016/j.autrev.2020.102554. PubMed DOI PMC

Abani O., Abbas A., Abbas F., Abbas M., Abbasi S., Abbass H., Abbott A., Abdallah N., Abdelaziz A., Abdelfattah M., et al. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): A randomised controlled, open-label, platform trial. Lancet. 2021;397:2049–2059. doi: 10.1016/S0140-6736(21)00897-7. PubMed DOI PMC

Senefeld J.W., Klassen S.A., Ford S.K., Senese K.A., Wiggins C.C., Bostrom B.C., Thompson M.A., Baker S.E., Nicholson W.T., Johnson P.W., et al. Use of convalescent plasma in COVID-19 patients with immunosuppression. Transfusion. 2021;61:2503–2511. doi: 10.1111/trf.16525. PubMed DOI PMC

Raja M.A., Mendoza M.A., Villavicencio A., Anjan S., Reynolds J.M., Kittipibul V., Fernandez A., Guerra G., Camargo J.F., Simkins J., et al. COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature. Transplant. Rev. 2021;35:100588. doi: 10.1016/j.trre.2020.100588. PubMed DOI PMC

Rahman F., Liu S.T.H., Taimur S., Jacobs S., Sullivan T., Dunn D., Baneman E., Fuller R., Aberg J.A., Bouvier N., et al. Treatment with convalescent plasma in solid organ transplant recipients with COVID-19: Experience at large transplant center in New York City. Clin. Transplant. 2020;34:e14089. doi: 10.1111/ctr.14089. PubMed DOI

Sarrell B.A., Bloch K., El Chediak A., Kumm K., Tracy K., Forbes R.C., Langone A., Thomas L., Schlendorf K., Trindade A.J., et al. Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients. Transpl. Infect. Dis. 2022;24:e13759. doi: 10.1111/tid.13759. PubMed DOI PMC

Kutzler H.L., Kuzaro H.A., Serrano O.K., Feingold A., Morgan G., Cheema F. Initial experience of bamlanivimab monotherapy use in solid organ transplant recipients. Transpl. Infect. Dis. 2021;23:e13662. doi: 10.1111/tid.13662. PubMed DOI

O’Brien M.P., Forleo-Neto E., Musser B.J., Isa F., Chan K.-C., Sarkar N., Bar K.J., Barnabas R.V., Barouch D.H., Cohen M.S., et al. Subcutaneous REGEN-COV Antibody Combination to Prevent COVID-19. N. Engl. J. Med. 2021;385:1184–1195. doi: 10.1056/NEJMoa2109682. PubMed DOI PMC

Dhand A., Razonable R.R. COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies. Curr. Transplant. Rep. 2022;9:26–34. doi: 10.1007/s40472-022-00357-2. PubMed DOI PMC